Medscape examines how people on GLP-1 medications can be judged both for their weight and for using a drug to treat it.
Recap by typeshit. Full story at Medscape.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Dr Vishnu walks through which of the two obesity drugs led to more weight loss, pointing to the head-to-head SURMOUNT-5 trial results.
Mounjaro and Zepbound brought in $14.9B in Q2 2026, though realized prices fell 13%. The bull case leans on retatrutide and Foundayo.
Loading…